Prenatal growth, early programming of cardiometabolic risk factors
Marij Gielen, PhD
PO Box 616
6200 MD Maastricht
T: (+31) (0)43 3881012
Marij Gielen, PhD became a researcher at Maastricht University in 2001. Whilst in this position, she got a formal PhD position in 2003, which resulted in a PhD in 2007. Since 2008 she is appointed as an assistant professor. Her research focus is 'programming of the cardiometabolic risk factors in the prenatal and early postnatal period'. One of the study populations is the East Flanders Prospective Twin Survey (EFPTS). The EFPTS is famous for its extensive information on zygosity, fetal membranes and placenta. Her expertise on prenatal growth contributed to the establishment of a twin register of the University of Birmingham, United Kingdom (Birmingham Registry for Twin and Heritability Studies; BiRTHS).
From 2007-2012 she also has been appointed as a research associate in Public Health and Epidemiology of the Unit of Urologic and Genetic Epidemiology at the University of Birmingham. At present the main research theme is on genetic and environmental determinants of infant growth and the influence of infant growth on cardiometabolic risk factors. In 2010 the SWOL granted the research proposal (€ 2.500,--; period 2 years (2010-2012)) making it possible to start investigating the role of telomeres in 'aging in utero'.
In 2010 she became in charge of the MEFAB (Maastricht Essential Fatty Acids Birth) Cohort, a cohort focussing on the role of essential fatty acids during pregnancy and further development of the child. This gives the oppertunity to study early programming of cardiometabolic risk factors in depth. She has published over 30 scientific research papers and she has (had) 3 PhD students under her supervision.
Marij Gielen is involved in teaching and developing scientific education, amongst which CAT (critical appraisal of a topic) education, of medical students.